Abstract
Uncontrolled growth of solid tumors will result in a hallmark hypoxic condition, whereby the key transcriptional regulator of hypoxia inducible factor-1α (HIF-1α) will be stabilized to activate the transcription of target genes that are responsible for the metabolism, proliferation, and metastasis of tumor cells. Targeting and inhibiting the transcriptional activity of HIF-1 may provide an interesting strategy for cancer therapy. In the present study, an immune library and a synthetic library were constructed for the phage display selection of Nbs against recombinant PAS B domain protein (rPasB) of HIF-1α. After panning and screening, seven different nanobodies (Nbs) were selected, of which five were confirmed via immunoprecipitation to target the native HIF-1α subunit. The inhibitory effect of the selected Nbs on HIF-1 induced activation of target genes has been evaluated after intracellular expression of these Nbs in HeLa cells. The dramatic inhibition of both intrabody formats on the expression of HIF-1-related target genes has been confirmed, which indicated the inhibitory efficacy of selected Nbs on the transcriptional activity of HIF-1.
Original language | English |
---|---|
Article number | 12335 |
Number of pages <span style="color:red"p> <font size="1.5"> ✽ </span> </font> | 19 |
Journal | International Journal of Molecular Sciences |
Volume | 22 |
Issue number | 22 |
DOIs | |
Publication status | Published - 15 Nov 2021 |
Keywords
- Cell Hypoxia/genetics
- Down-Regulation/drug effects
- Escherichia coli/genetics
- Female
- Gene Expression Regulation, Neoplastic
- HeLa Cells
- Humans
- Hypoxia-Inducible Factor 1, alpha Subunit/antagonists & inhibitors
- Protein Domains/genetics
- Single-Domain Antibodies/genetics
- Transcription, Genetic/drug effects
- Transfection
- Uterine Cervical Neoplasms/genetics